Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 13/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.37 |
| ▸ | PLAT | P00750 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7306798 | 0.96 | F2 (0.45) | F2 | |
| SCHEMBL8947619 | 0.92 | F2 (0.45) | F2 | |
| SCHEMBL7307422 | 0.90 | F2 (0.55) | F2 | |
| Trifluoroacetic Acid SCHEMBL8948194 | 0.90 | F2 (0.46) | F2PLAUPLAT | |
| SCHEMBL8947853 | 0.87 | F2 (0.49) | F2PLAUPLAT | |
| SCHEMBL8947709 | 0.83 | F2 (0.48) | F2PLAUPLAT | |
| Hydrochloric Acid SCHEMBL7306153 | 0.81 | F2 (0.55) | F2PLAUPLAT | |
| SCHEMBL8947639 | 0.81 | F2 (0.55) | F2 | |
| SCHEMBL8947782 | 0.81 | F2 (0.35) | F2 | |
| Hydrochloric Acid SCHEMBL9168683 | 0.81 | F2 (0.46) | F2PLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559046-B1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | HOFFMANN LA ROCHE (CH) | 2001-07-11 | — | — | EP | disclosed |
| US-5578594-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-11-26 | — | — | US | disclosed |
| US-5405854-A | Anticoagulants | HOFFMANN-LA ROCHE INC. (US) | 1995-04-11 | — | — | US | disclosed |
| EP-0559046-A1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1993-09-08 | — | — | EP | disclosed |